SE9803623D0 - New therapeutic application - Google Patents
New therapeutic applicationInfo
- Publication number
- SE9803623D0 SE9803623D0 SE9803623A SE9803623A SE9803623D0 SE 9803623 D0 SE9803623 D0 SE 9803623D0 SE 9803623 A SE9803623 A SE 9803623A SE 9803623 A SE9803623 A SE 9803623A SE 9803623 D0 SE9803623 D0 SE 9803623D0
- Authority
- SE
- Sweden
- Prior art keywords
- new therapeutic
- therapeutic application
- analogues
- mammals
- lipid
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000000563 Hyperlipoproteinemia Type II Diseases 0.000 abstract 1
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010045261 Type IIa hyperlipidaemia Diseases 0.000 abstract 1
- 239000003524 antilipemic agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 201000001386 familial hypercholesterolemia Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803623A SE9803623D0 (sv) | 1998-10-22 | 1998-10-22 | New therapeutic application |
JP2000576870A JP2002527486A (ja) | 1998-10-22 | 1999-10-21 | 家族性高コレステロール血症をもつ哺乳動物の治療のための成長ホルモンまたはその類似体の使用 |
US09/830,077 US6559289B1 (en) | 1998-10-22 | 1999-10-21 | Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
DE69927599T DE69927599T2 (de) | 1998-10-22 | 1999-10-21 | Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie |
CA002342794A CA2342794A1 (en) | 1998-10-22 | 1999-10-21 | Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
PCT/SE1999/001898 WO2000023097A1 (en) | 1998-10-22 | 1999-10-21 | Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
EP99970604A EP1124571B1 (en) | 1998-10-22 | 1999-10-21 | Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
AU14288/00A AU764779B2 (en) | 1998-10-22 | 1999-10-21 | Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
AT99970604T ATE305795T1 (de) | 1998-10-22 | 1999-10-21 | Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803623A SE9803623D0 (sv) | 1998-10-22 | 1998-10-22 | New therapeutic application |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9803623D0 true SE9803623D0 (sv) | 1998-10-22 |
Family
ID=20413054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9803623A SE9803623D0 (sv) | 1998-10-22 | 1998-10-22 | New therapeutic application |
Country Status (9)
Country | Link |
---|---|
US (1) | US6559289B1 (sv) |
EP (1) | EP1124571B1 (sv) |
JP (1) | JP2002527486A (sv) |
AT (1) | ATE305795T1 (sv) |
AU (1) | AU764779B2 (sv) |
CA (1) | CA2342794A1 (sv) |
DE (1) | DE69927599T2 (sv) |
SE (1) | SE9803623D0 (sv) |
WO (1) | WO2000023097A1 (sv) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7785567B2 (en) | 2002-08-23 | 2010-08-31 | Valorisation-Recherche, Société en Commandite | Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia |
BRPI0507302A (pt) * | 2004-01-29 | 2007-06-26 | Applied Research Systems | método e composições para o tratamento da lipodistrofia |
KR100969085B1 (ko) * | 2007-09-05 | 2010-07-09 | 현대자동차주식회사 | 하이브리드 차량용 동력전달장치 |
-
1998
- 1998-10-22 SE SE9803623A patent/SE9803623D0/sv unknown
-
1999
- 1999-10-21 CA CA002342794A patent/CA2342794A1/en not_active Abandoned
- 1999-10-21 US US09/830,077 patent/US6559289B1/en not_active Expired - Fee Related
- 1999-10-21 DE DE69927599T patent/DE69927599T2/de not_active Expired - Fee Related
- 1999-10-21 AU AU14288/00A patent/AU764779B2/en not_active Ceased
- 1999-10-21 AT AT99970604T patent/ATE305795T1/de not_active IP Right Cessation
- 1999-10-21 EP EP99970604A patent/EP1124571B1/en not_active Expired - Lifetime
- 1999-10-21 WO PCT/SE1999/001898 patent/WO2000023097A1/en active IP Right Grant
- 1999-10-21 JP JP2000576870A patent/JP2002527486A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2000023097A1 (en) | 2000-04-27 |
AU764779B2 (en) | 2003-08-28 |
DE69927599T2 (de) | 2006-07-20 |
EP1124571A1 (en) | 2001-08-22 |
ATE305795T1 (de) | 2005-10-15 |
DE69927599D1 (de) | 2006-02-16 |
US6559289B1 (en) | 2003-05-06 |
JP2002527486A (ja) | 2002-08-27 |
EP1124571B1 (en) | 2005-10-05 |
CA2342794A1 (en) | 2000-04-27 |
AU1428800A (en) | 2000-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7031500A (en) | Therapeutic quinazoline compounds | |
ATE322280T1 (de) | Verwendung von daptomycin | |
NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
HUP0402661A3 (en) | Formulation and dosage form for the controlled delivery of therapeutic agents | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
DE69923076D1 (de) | Transthorakale arzneimittelabgabevorrichtung | |
DE60121988D1 (de) | Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln | |
DE69807634D1 (de) | Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen | |
DE69838099D1 (de) | Quinazolinenon-enthaltende pharmazeutische zusammensetzungen zur verhütung von gefässneubildung und zur behandlung von bösartigen neubildungen | |
HUP0301380A3 (en) | Use of rosuvastatin (zd-4522) for producing pharmaceutical composition using in the treatment of heterozygous familial hypercholesterolemia | |
AU2002213698A1 (en) | Needleless syringe for the subcutaneous delivery of therapeutic agents | |
DE60024414D1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
BRPI0410049A (pt) | composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
DE60016460D1 (de) | Verwendungen und zusammenstellungen von nitratestern als sedativa | |
PT934065E (pt) | Compostos farmaceuticos | |
GB9907571D0 (en) | Compounds | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
DE60222383D1 (de) | Medikament zur verabreichung von amifostin und verwandten wirkstoffen | |
SE9803623D0 (sv) | New therapeutic application | |
HUP0000110A2 (hu) | Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények | |
SE0004827D0 (sv) | Therapeutic compounds | |
BR0206918A (pt) | Uso de iloperidona | |
IL125983A0 (en) | Pharmaceutical composition comprising factor xiiia | |
ZA977042B (en) | Nasal administration of agents for treatment of delayed onset emesis. |